Combined chemotherapy with decetaxel and nedaplatin for advanced esophageal cancer, phaseI/II study.

Combined chemotherapy with decetaxel and nedaplatin for advanced esophageal cancer, phaseI/II study. - Combined chemotherapy with decetaxel and nedaplatin.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002037

Enrollment

Registered

2009-06-03

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Docetaxel and nedaplatin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: squamous cell carcinoma inoperable

Exclusion criteria

Exclusion criteria: double cancer

Design outcomes

Primary

Measure	Time frame
Evaluation of effectiveness after therapy	—

Secondary

Measure	Time frame
Evaluation of safety after therapy	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026